Background: The two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against COVID-19 disease in clinical trials of children and young people (CYP). Consequently, we investigated the uptake, safety, effectiveness and waning of the protective effect of the BNT162b2 against symptomatic COVID-19 in CYP aged 12–17 years in Scotland. Methods: The analysis of the vaccine uptake was based on information from the Turas Vaccination Management Tool, inclusive of Mar 1, 2022. Vaccine safety was evaluated using national data on hospital admissions and General Practice (GP) consultations, through a self-controlled case series (SCCS) design, investigating 17 health outcomes of interest. Vaccine effectiveness (VE) against symptomatic...
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2 omicron varian...
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
Supported by the U.K. Health Security Agency, the U.K. Department of Health and Social Care (with co...
Background: The two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against...
This study is part of the EAVE II project. EAVE II is funded by the MRC (MC_PC_19075) with the suppo...
Funding: This research is part of the Data and Connectivity National Core Study, led by Health Data ...
BACKGROUND: Little is known about vaccine effectiveness over time among adolescents, especially agai...
Background: We aimed to explore the effectiveness of one-dose BNT162b2 vaccination upon SARS-CoV-2 i...
Funding: EAVE II is supported by the Medical Research Council (MR/R008345/1) with the support of BRE...
Background: Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hosp...
BackgroundThe dynamics of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and sev...
VK is funded by an NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the UK Medical Res...
OBJECTIVE: To compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and mRNA-1273 (Modern...
BACKGROUND: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
BackgroundSeveral SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospita...
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2 omicron varian...
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
Supported by the U.K. Health Security Agency, the U.K. Department of Health and Social Care (with co...
Background: The two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against...
This study is part of the EAVE II project. EAVE II is funded by the MRC (MC_PC_19075) with the suppo...
Funding: This research is part of the Data and Connectivity National Core Study, led by Health Data ...
BACKGROUND: Little is known about vaccine effectiveness over time among adolescents, especially agai...
Background: We aimed to explore the effectiveness of one-dose BNT162b2 vaccination upon SARS-CoV-2 i...
Funding: EAVE II is supported by the Medical Research Council (MR/R008345/1) with the support of BRE...
Background: Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hosp...
BackgroundThe dynamics of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and sev...
VK is funded by an NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the UK Medical Res...
OBJECTIVE: To compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and mRNA-1273 (Modern...
BACKGROUND: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
BackgroundSeveral SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospita...
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2 omicron varian...
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
Supported by the U.K. Health Security Agency, the U.K. Department of Health and Social Care (with co...